Seth Harmon
Director of Finance/CFO presso VIRIDIAN THERAPEUTICS, INC.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Seth Harmon is currently the Chief Financial & Accounting Officer at Viridian Therapeutics, Inc. Prior to his current position, he served as the Chief Financial Officer at BioNTech SE from 2020 to 2023.
Before that, he was the Vice President-Finance at BioNTech US, Inc. from 2017 to 2020.
Mr. Harmon completed his undergraduate degree at Bowdoin College and holds a graduate degree in MBA from Northeastern University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
10/11/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Seth Harmon
Società | Posizione | Inizio |
---|---|---|
VIRIDIAN THERAPEUTICS, INC. | Director of Finance/CFO | 12/09/2023 |
Precedenti posizioni note di Seth Harmon
Società | Posizione | Fine |
---|---|---|
BIONTECH SE | Director of Finance/CFO | 01/05/2023 |
NEON THERAPEUTICS, INC. | Corporate Officer/Principal | 01/05/2020 |
Formazione di Seth Harmon
Bowdoin College | Undergraduate Degree |
Northeastern University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
BIONTECH SE | Health Technology |
VIRIDIAN THERAPEUTICS, INC. | Health Technology |
Aziende private | 1 |
---|---|
BioNTech US, Inc.
BioNTech US, Inc. BiotechnologyHealth Technology BioNTech US, Inc. develops novel therapeutics leveraging neoantigen biology to treat cancer. It offers NEO-PV-01, a personalized neoantigen vaccine that builds upon initial clinical trials. The company was founded by James P. Allison, Edward J. Fritsch, Nir Hacohen, Eric S. Lander, Robert Schreiber, Ton Schumacher and Catherine Wu on October 21, 2013 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Seth Harmon